Lifestream and Polymer resolve patent wrangle:
This article was originally published in Clinica
Lifestream Technologies has reached a settlement in its patent infringement lawsuit filed against Polymer Technology Systems, a private developer of rapid cholesterol tests. In the agreement, Polymer is to make royalty payments to Lifestream for future sales of products incorporating the latter's HDL (high density lipoprotein) technology, the subject of the dispute. The resolution follows shortly after Lifestream won its appeal to have overturned an initial ruling that found Polymer not guilty of infringement.